Error: Could not add to watchlist. X
+ Watchlist

IFM - HBM Global Biotechnology Fund

HBMGBEU:LE
96.95
EUR
As of 12:59 AM EDT 5/17/2017
Fund Type
Open-End Fund
52Wk Range
96.95 - 100.00
Before it's here, it's on the Bloomberg Terminal.
Learn More
52Wk Range
96.95 - 100.00
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 05/17/2017)
96.95
Total Assets (m USD) (on 05/17/2017)
29.930
Inception Date
12/30/2011
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
-
Front Load Fee
-
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.50%
Expense Ratio
0.00%
Profile
HBM Global Biotechnology Fund is an open-end fund incorporated in Liechtenstein. The fund's objective is to achieve long-term growth, which outperforms the reference index - NASDAQ Biotech Index in USD as far as possible. The fund invests mainly in shares of global firms, which operate in bio-technology and bio-pharmacy branches.
Address
IFM Independent Fund Management AG
Austrasse 9
Postfach 1121
LI 9490 Vaduz
Liechtenstein
Phone
423 235 04 50 TEL
Website
www.ifm.li